Brief: Ampio Receives U.S. FDA Approval Of Special Protocol Assessment Of A Clinical Protocol

Ampio Pharmaceuticals

14/06/2019 12:34

June 14 (Reuters) - Ampio Pharmaceuticals Inc  AMPE.A :
    * AMPIO REGULATORY AND CLINICAL UPDATE
    * AMPIO PHARMACEUTICALS INC - IDENTIFIED AND ENGAGED 15
CLINICAL
SITES FOR TRIAL (AP-013) AND PATIENT IDENTIFICATION IS UNDERWAY
    * AMPIO - FDA RESPONSE NOTED IT COMPLETED REVIEW, AND AGREES
THAT
DESIGN & PLANNED ANALYSIS OF STUDY ADDRESSES OBJECTIVES FOR
REGULATORY SUBMISSION
    * AMPIO PHARMACEUTICALS - RECEIVED FDA APPROVAL OF SPECIAL
PROTOCOL ASSESSMENT OF A CLINICAL PROTOCOL
    * AMPIO PHARMACEUTICALS - CLINICAL PROTOCOL IS FOR STUDY OF
INTRA-ARTICULAR INJECTION OF AMPION IN ADULTS WITH PAIN DUE TO
SEVERE OSTEOARTHRITIS OF KNEE

Source text for Eikon:  ID:nPn1hfQcpa 
Further company coverage:  AMPE.A 

 ((Reuters.Briefs@thomsonreuters.com;))